Sign up United Kingdom
Proactive Investors - Run By Investors For Investors
Markets

Patagonia Gold shares drop as it cuts full year production guidance

A look at some of the top risers and fallers in London on Wednesday
gold
Patagonia's Cap Oeste mine will be closed for maintenance from Sunday

Patagonia Gold plc (LON:PGD) shares are down 8.7% to 89p after saying production at the Cap Oeste mine in Argentina in the quarter ended June was hit by labour disruptions and severe weather conditions. 

During the period, a national labour strike in Argentina and below freezing temperatures in May and June affected production. 

The Cap Oeste mine is expected to be closed for maintenance on July 15, it added. 

As a result, the group cut its 2018 production guidance to 45,000 ounces of gold equivalent from the 59,083 ounces previously estimated. 

Eurasia Mining plc (LON:EUA) shares gained after the Ministry of Natural Resources (MNR) approved its application for a mining permit at Monchetundra Mine in Russia.

The company said the MNR approval was the final relevant Russian agency approval required for the mining permit application.

The mine permit application has now been delivered to the office of Prime Minister Dmitry Medvedev for final authorisation.

Shares rose 7.4% to 0.44p.

ECR Minerals shares jump as it raises funds to advance Australian operations

ECR Minerals PLC (LON:ECR) said it now has sufficient working capital against current operational plans to last until the third quarter of next year after a successful equity raise. 

Shares in the company shot up 175 to 0.79p.

The group issued 92.9mln shares at 0.7p each to raise £650,000. If all warrants holders choose to exercise the warrants that have been attached to the newly issued shares, this would generate about £1,045,000 before expenses.

ECR said the funds raised would be used to expand its Australian operations, including an accelerated development programme at the Blue Moon gold prospect in the Victoria region.

The announcement follows the news of drilling success at Blue Moon.

Solo Oil shares boosted by Aminex farm-out agreement

Solo Oil PLC  (LON:SOLO) shares have received a boost after Aminex plc (LON:AEX) announced a farm-out agreement for the Ruvuma production sharing agreement.

Ruvuma contains the Ntorya discovery where Solo owns a 25% interest.

“This development provides a clear commercial and technical validation of the Ntorya project, which we hope will now move quickly towards production,” said Solo executive chairman Neil Ritson.

Shares in Solo jumped 26% to 2.90p.  

Low & Bonar PLC (LON:LWB) shares declined after the performance materials maker’s half-year underlying profit before tax halved.

The underlying profit before tax in the six months to the end of May plunged to £6.5mln from £13.1mln the year before. The figure excludes a non-cash write-down of £13.3mln in the value of the Coated Technical Textiles (CTT) business.

"The first half has been challenging. Raw material prices have increased more than we anticipated and we have not been able to pass these on in full. Our operational performance is not yet at the level I expect, although we are confident that the organisational changes which we are implementing will improve this,” said Philip de Klerk, who took over as the chief executive officer in January.

Shares dropped 8.3% to 43.90p. 

Aminex shares gain after subsidiary signs farm-out agreement

Aminex PLC (LON:AEX) shares jumped 33% to 2.9p after telling investors its subsidiary, Ndovu Resources Limited, has signed a binding farm-out agreement with The Zubair Corporation for the Ruvuma production sharing agreement (PSA).

Zubair plans to assign its interest in the farm-out to ARA Petroleum Tanzania Ltd, which will be an affiliate of Eclipse Investments LLC - Aminex’s largest shareholder. 

ARA will become operator in exchange for a 50% working interest in Ruvuma PSA, which is located in southern Tanzania and includes the Ntorya project.

Aminex said the farm-out will accelerate the development of the Ntorya project, carry it through to a minimum gross production rate of 40mln cubic feet per day and be self-funded through a full field development project.

"With the Ntorya project carried to a minimum level of production it is now expected that the Company will be self-funded for further development,” said Aminex chief executive Jay Bhattacherjee.

“Aminex continues to develop its Kiliwani and Nyuni assets and is undertaking a review of other opportunities which will deliver robust shareholder returns."

Frenkel Topping Group PLC (LON:FEN), a financial advisor and asset manager, said it expects profits for the year to be below market estimates after increasing marketing spend to maintain market share.

Shares fell 17% to 38p.

The company said it experienced a “softer trading background than anticipated” and lost some clients during the year.

Changes in the Ogden discount rate – used to calculate payouts for injury claims caused in motor vehicle accidents -- also resulted in larger amounts paid out to victims. 

ReNeuron rallies on exclusivity agreement

ReNeuron Group PLC (LON:RENE) was on the front foot after signing an exclusivity agreement worth up to US$5mln with an unnamed US-based speciality pharmaceutical company.

The agreement comes ahead of potentially licensing out its hRPC retinal stem cell technology and therapeutic programmes.

Under the deal, ReNeuron will receive a non-refundable US$2.5mln payment for granting a three-month period of exclusivity and will get the same again following the completion of "certain due diligence activities" during that time.

The company hopes the agreement will lead to a definitive accord later this year.

Shares jumped 19% to 97p.

PCI-PAL PLC  (LON:PCIP) shares gained 12% to 31p after the payment processing company said it expects recurring revenues to increase for the year after achieving contract wins.

Recurring revenues are expected to have increased to more than 75% of total turnover in the year to June 2018, compared to 65% last year.

The company signed 48 contracts for its Capita Pay 360 and NewVoiceMedia platforms along with 15 new contracts on the new Amazon Web Services-based platform since its launch in the year.

Indivior and Safestyle UK shares tank 

Going the other way, shares in Indivior PLC (LON:INDV) plunged 32% to 255p after saying sales and profits will be lower than expected this year.

The company’s star drug for opiate drug addiction Suboxone has come under pressure from copycat rivals.

Last month, Indian giant Dr Reddy’s launched a cut-price version of Suboxone. Indivior went to court to prevent Dr Reddy from selling the product, and while a temporary restraining order was granted, the company said it has already seen the impact from the launch of the product into the US market. 

Safestyle UK PLC (LON:SFE) was also under the cosh after saying it expects to report full year revenues below market forecasts and to post a “small underlying loss before tax”.

The maker of PVCu replacement windows and doors blamed reduced gross margin and increased operating costs.

The company was hit by weaker consumer spending on higher value home improvement products and the loss of significant numbers of canvass, sales and installation staff to competitor NIAMIC Developments Ltd.

Safestyle is taking legal action against NIAMIC, which trades as SafeGlaze, and said it would update the market on the issue in due course.

The group expects non-recurring exceptional cash costs of £6mln in the current financial year, including the costs of legal action and its restructuring along with a fine after a Health & Safety Executive investigation.

Shares fell 18.5% to 40.5p. 


No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use